MedRhythms, Inc.

Industry

  • Digital Health
    • Disease Management
    • Artificial Intelligence
  • Biotechnology
  • Pharmaceuticals
See more in Biomedtracker

Latest on MedRhythms, Inc.

Medtech Insight

News We’re Watching: MedRhythms App Gets FDA Clearance, Recalls For Megadyne And Draeger, Elixir Stent Trial Moves Ahead

 
• By Marion Webb, Reed Miller, and Brian Bossetta

MedRhythms Wins FDA Clearance For Digital Therapeutics To Improve Walking In Stroke Patients MedRhythms, Inc. announced on 15 July that it has received US Food and Drug Administration clearance for

Medtech Insight

Happify Health Collaborates With Biogen To Support People Living With Multiple Sclerosis

 
• By Marion Webb

Digital therapeutics company Happify Health and Biogen Pharma announced on 22 June they will join forces to provide digital health support for people with multiple sclerosis (MS). The Happify Heal

Scrip

Deal Watch: Novo Nordisk Links With Flagship To Create Cardiometabolic, Rare Disease Portfolio

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, Flagship Hope Combined Ef

Medtech Insight

‘Training People To Be Healthier’: Digital Therapeutics Programmed For Growth

 
• By Marion Webb

Health techs’ push to digitize medicine has led to an explosion of innovative solutions that seek to engage and empower consumers and patients to participate in their own health. Digital therapeutics,